✦ LIBER ✦

Tie2 receptor tyrosine kinase, a major mediator of tumor necrosis factor α–induced angiogenesis in rheumatoid arthritis

✍ Scribed by Laura M. DeBusk; Ying Chen; Toshihide Nishishita; Jin Chen; James W. Thomas; Pengnain Charles Lin

Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 460 KB
Volume: 48
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.11213

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Suppression of collagen-induced arthriti

Suppression of collagen-induced arthritis through adenovirus-mediated transfer of a modified tumor necrosis factor α receptor gene

✍ Christine H. Le; A. Graham Nicolson; Alejandro Morales; K. Lea Sewell 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 830 KB

## Objective: To evaluate the efficacy of systemic and intraarticular adenoviral transfer of a modified tumor necrosis factor alpha receptor (tnf alphar) gene and its expression in rat collagen-induced arthritis (cia). ## Methods: Rats with cia received injections of replication-deficient adenovi

Unmasking of a protective tumor necrosis

Unmasking of a protective tumor necrosis factor receptor I–mediated signal in the collagen-induced arthritis model

✍ Cheryll Williams-Skipp; Thiagarajan Raman; Robert J. Valuck; Herschel Watkins; B 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 524 KB

Induction of tumor necrosis factor α pro

Induction of tumor necrosis factor α production by adhered human monocytes: A key role for Fcγ receptor type IIIA in rheumatoid arthritis

✍ Vikki M. Abrahams; Geraldine Cambridge; Peter M. Lydyard; Jonathan C. W. Edwards 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 360 KB 👁 1 views

Normalization of A2A and A3 adenosine re

Normalization of A2A and A3 adenosine receptor up-regulation in rheumatoid arthritis patients by treatment with anti–tumor necrosis factor α but not methotrexate

✍ Katia Varani; Alfonso Massara; Fabrizio Vincenzi; Alice Tosi; Melissa Padovan; F 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 342 KB 👁 2 views

Blocking ERK-1/2 reduces tumor necrosis

Blocking ERK-1/2 reduces tumor necrosis factor α–induced interleukin-18 bioactivity in rheumatoid arthritis synovial fibroblasts by induction of interleukin-18 binding protein A

✍ Hubert Marotte; Salahuddin Ahmed; Jeffrey H. Ruth; Alisa E. Koch 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 338 KB 👁 1 views

Assessment of antibodies to double-stran

Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor α: Findings in open-label and randomized placebo-controlled trials

✍ P. J. Charles; R. J. T. Smeenk; J. De Jong; M. Feldmann; R. N. Maini 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB 👁 2 views

Objective. To compare the incidence of antidouble-stranded DNA (anti-dsDNA) antibodies in rheumatoid arthritis (RA) patients receiving either single or multiple doses of a chimeric anti-tumor necrosis factor ␣ (anti-TNF␣) antibody or placebo infusions, with or without methotrexate, in open-label, ra